Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure.
Engelmann C, Sheikh M, Sharma S, Kondo T, Loeffler-Wirth H, Zheng YB, Novelli S, Hall A, Kerbert AJC, Macnaughtan J, Mookerjee R, Habtesion A, Davies N, Ali T, Gupta S, Andreola F, Jalan R.
Engelmann C, et al. Among authors: ali t.
J Hepatol. 2020 Jul;73(1):102-112. doi: 10.1016/j.jhep.2020.01.011. Epub 2020 Jan 24.
J Hepatol. 2020.
PMID: 31987990